Influences of Ivabradine treatment on serum levels of cardiac biomarkers sST2, GDF-15, suPAR and H-FABP in patients with chronic heart failure

Chronic heart failure (CHF) represents a major cause of hospitalization and death. Recent evidence shows that novel biomarkers such as soluble suppression of tumorigenicity (sST2), growth-differentiation factor-15 (GDF-15), soluble urokinase plasminogen activator receptor (suPAR) and heart-type fatt...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Acta Pharmacol Sin
Autori principali: Jirak, Peter, Fejzic, Dzeneta, Paar, Vera, Wernly, Bernhard, Pistulli, Rudin, Rohm, Ilonka, Jung, Christian, Hoppe, Uta C, Schulze, P Christian, Lichtenauer, Michael, Yilmaz, Atilla, Kretzschmar, Daniel
Natura: Artigo
Lingua:Inglês
Pubblicazione: Nature Publishing Group UK 2017
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6289366/
https://ncbi.nlm.nih.gov/pubmed/29239349
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/aps.2017.167
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi